Physician

Jay Shah, M.D.

According to 2025 Medicare claims, Jay Shah, M.D. (NPI: 1841589926) practices neuropsychiatry in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF CLAIFORNIA UNIV NEURSCIENCES (NPI: 1205884210; TIN: 954137974) and primary practice location at 92868-3201. Shah is affiliated with the UC Irvine Health Accountable Care Organization (ACO ID: A3799), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 244 traditional Medicare patients, billed 362 HCPCS/CPT codes, and received $36,491 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 293 prescription claims across 65 beneficiaries totaling $38,973 in drug costs, led by Neurontin (Gabapentin). 2021 DME data shows 34 claims. Open Payments data shows 7 records totaling $15,015. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $5,223 to $38,973. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	183	268	$28,723
2017	218	301	$32,394
2018	174	306	$31,320
2019	211	384	$38,426
2020	229	391	$39,540
2021	235	394	$41,299
2022	259	428	$42,691
2023	251	400	$40,653
2024	244	362	$36,491

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	47	$5,223
2016	N/R	15	$121
2017	12	47	$298
2018	25	127	$9,698
2019	31	93	$6,537
2020	44	140	$14,603
2021	55	190	$19,871
2022	57	226	$17,810
2023	68	285	$43,748
2024	65	293	$38,973

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	34	$992
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	57	57	$146
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	21	21	$106
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	35	93	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	29	34	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	38	39	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Neurontin	Gabapentin	14	420	$20,376
Depakote Er	Divalproex Sodium	14	420	$4,332
Carbamazepine	Carbamazepine	12	427	$1,469
Levetiracetam	Levetiracetam	30	2,317	$960
Atorvastatin Calcium	Atorvastatin Calcium	69	5,790	$845

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	7	$15,015	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jay Shah, M.D.?

Tedicare shows public-source Medicare data for Jay Shah, M.D. (NPI 1841589926), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jay Shah, M.D. have ACO affiliation data?

Jay Shah, M.D. is shown with ACO affiliation data for UC Irvine Health Accountable Care Organization (MSSP, ACO ID A3799).

What billing organization is linked to Jay Shah, M.D.?

Jay Shah, M.D. is linked to REGENTS OF THE UNIVERSITY OF CLAIFORNIA UNIV NEURSCIENCES (billing NPI 1205884210) in the available physician profile data.

Does Jay Shah, M.D. have Open Payments data?

Jay Shah, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.